Epilepsy surgery risk? study checks stomach emptying with quick ultrasound
NCT ID NCT07421661
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether people with epilepsy digest food and liquids at a normal rate after following standard pre-surgery fasting rules. Researchers will use a quick, painless bedside ultrasound to check the stomach contents of 30 adults with epilepsy before their scheduled surgery. The goal is to see if current fasting guidelines are safe for epilepsy patients or if they need to be changed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients with epilepsy who are scheduled for surgery where general anesthesia will be used.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosis of epilepsy (confirmed by history or medical records and classified as per 2025 ILAE classification for seizures). 2. Scheduled for elective neurologic (e.g., epilepsy surgery) or non-neurologic surgery under anesthesia. 3. 18 years of age or older. 4. Adherence to standard fasting guidelines (verified by patient report). Exclusion Criteria: 1. Refusal/withdrawal of consent. 2. Noncompliance with fasting guidelines. 3. Pregnancy. 4. Patients with continuous treatment on GLP/GIP 1 analogues without a washout period. 5. Parkinsons patients with proven gastroparesis. 6. Diabetic neuropathy with gastroparesis 7. Patients on Prokinetic agents (Metoclopramide/ Erythromycin) 8. Neuro muscular/ neurodegenerative disorders with gastroparesis. 9. Uncontrolled hypothyroidism. 10. Bowel obstruction
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Epilepsy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can lavender and lullabies help kids with epilepsy sleep better?
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can a Comfort-Focused education program improve life with epilepsy?
- Can video games rewire young brains after injury?
- High-Fat Diet's effect on epilepsy: scientists track brain signals
- Epilepsy drug candidate put to the test in healthy volunteers